Making Science Group Statistics

Total Valuation

BME:MAKS has a market cap or net worth of EUR 78.73 million. The enterprise value is 127.67 million.

Market Cap	78.73M
Enterprise Value	127.67M

Important Dates

The last earnings date was Thursday, April 17, 2025.

Earnings Date	Apr 17, 2025
Ex-Dividend Date	n/a

Share Statistics

BME:MAKS has 8.80 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	8.80M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.89%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.48%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.32
PB Ratio	4.06
P/TBV Ratio	n/a
P/FCF Ratio	6.11
P/OCF Ratio	5.78
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 28.38, with an EV/FCF ratio of 9.90.

EV / Earnings	-67.94
EV / Sales	0.52
EV / EBITDA	28.38
EV / EBIT	29.89
EV / FCF	9.90

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 3.65.

Current Ratio	0.74
Quick Ratio	0.69
Debt / Equity	3.65
Debt / EBITDA	15.70
Debt / FCF	5.49
Interest Coverage	0.82

Financial Efficiency

Return on equity (ROE) is -12.93% and return on invested capital (ROIC) is 3.86%.

Return on Equity (ROE)	-12.93%
Return on Assets (ROA)	1.86%
Return on Invested Capital (ROIC)	3.86%
Return on Capital Employed (ROCE)	8.04%
Revenue Per Employee	236,743
Profits Per Employee	-1,795
Employee Count	1,043
Asset Turnover	1.72
Inventory Turnover	66.72

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.90% in the last 52 weeks. The beta is 1.33, so BME:MAKS's price volatility has been higher than the market average.

Beta (5Y)	1.33
52-Week Price Change	+0.90%
50-Day Moving Average	8.72
200-Day Moving Average	8.45
Relative Strength Index (RSI)	50.63
Average Volume (20 Days)	3,480

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BME:MAKS had revenue of EUR 247.87 million and -1.88 million in losses. Loss per share was -0.22.

Revenue	247.87M
Gross Profit	24.78M
Operating Income	4.28M
Pretax Income	602,502
Net Income	-1.88M
EBITDA	2.87M
EBIT	4.28M
Loss Per Share	-0.22

Full Income Statement

Balance Sheet

The company has 22.23 million in cash and 70.76 million in debt, giving a net cash position of -48.53 million or -5.52 per share.

Cash & Cash Equivalents	22.23M
Total Debt	70.76M
Net Cash	-48.53M
Net Cash Per Share	-5.52
Equity (Book Value)	19.41M
Book Value Per Share	2.17
Working Capital	-27.37M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.63 million and capital expenditures -736,138, giving a free cash flow of 12.89 million.

Operating Cash Flow	13.63M
Capital Expenditures	-736,138
Free Cash Flow	12.89M
FCF Per Share	1.47

Full Cash Flow Statement

Margins

Gross margin is 10.00%, with operating and profit margins of 1.73% and -0.76%.

Gross Margin	10.00%
Operating Margin	1.73%
Pretax Margin	0.24%
Profit Margin	-0.76%
EBITDA Margin	1.16%
EBIT Margin	1.73%
FCF Margin	5.20%

Dividends & Yields

BME:MAKS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2.39%
FCF Yield	16.37%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BME:MAKS has an Altman Z-Score of 1.75. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.75
Piotroski F-Score	n/a